AU Patent

AU2024227498A1 — Methods for inhibition of hao1 (hydroxyacid oxidase 1 (glycolate oxidase) gene expression

Assigned to Alnylam Pharmaceuticals Inc · Expires 2025-01-09 · 1y expired

What this patent protects

The invention relates methods of using RNAi agents to inhibit expression of HAOI and methods of treating subjects having, e.g., PHI. 21250685_1 (GHMatters) P112932.AU.1

USPTO Abstract

The invention relates methods of using RNAi agents to inhibit expression of HAOI and methods of treating subjects having, e.g., PHI. 21250685_1 (GHMatters) P112932.AU.1

Drugs covered by this patent

Patent Metadata

Patent number
AU2024227498A1
Jurisdiction
AU
Classification
—
Expires
2025-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Alnylam Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.